Food-borne clenbuterol may have potential for cardiovascular effects with chronic exposure (commentary)

Journal of Toxicology - Clinical Toxicology

Volumn 39, Issue 4, 2001, Pages 345-348

  Chan, T Y K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CLENBUTEROL;

CARDIOTOXICITY; CARDIOVASCULAR RESPONSE; CONFERENCE PAPER; DRUG EFFECT; FOOD CONTAMINATION; HUMAN; INTRINSIC SYMPATHOMIMETIC ACTIVITY; LONG TERM EXPOSURE; MUSCLE MASS; NONHUMAN;

ADRENERGIC BETA-AGONISTS; ANIMALS; CHRONIC DISEASE; CLENBUTEROL; FOOD CONTAMINATION; HEMODYNAMIC PROCESSES; HUMANS; MEAT;

EID: 0034882457     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-100105153     Document Type: Conference Paper

References (34)

1. Illegal use of beta-adrenergic agonists in the United States
2. Illegal use of beta-adrenergic agonists: European community
3. Health hazards due to clenbuterol residues in food
4. Effects of the cyclo-oxygenase inhibitor, fenbufen, on clenbuterol-induced hypertrophy of cardiac and skeletal muscle of rats
5. Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes
6. Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features
7. Polyamine-mediated hypertrophy induced by clenbuterol in the mouse
8. Beta-Agonist induced alterations in organ weights and protein content: Comparison of racemic clenbuterol and its enantiomers
9. Multiple actions of βadrenergic agonists on skeletal muscle and adipose tissue
10. Newer drugs used to enhance sporting performance
11. Clenbuterol: A substitute for anabolic steroids?
12. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters
13. Clenbuterol and anabolic steroids: A previously unreported cause of myocardial infarction with normal coronary arteriograms
14. End-stage renal disease in a bodybuilder: A multifactorial process or simply doping?
15. Left ventricular wall thickening does occur in elite power athletes with or without anabolic steroid use
16. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension
17. Increased prevalence of cardiac arrhythmias and transient episodes of myocardial ischemia in hypertensives with left ventricular hypertrophy but without clinical history of coronary heart disease
18. Effect of chronotropic and inotropic stimulation on the coronary pressure flow relation in left ventricular hypertrophy
19. Use of sympathomimetic drugs leads to increased risk of hospitalization for arrhythmias in patients with congestive heart failure
20. Clonidine and beta-agonists induce hyperthermia in rats at a high ambient temperature
21. Separate and combined influences of dehydration and hyperthermia on cardiovascular responses to exercise
22. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents
23. The cardiac toxicity of anabolic steroids prog
24. Anabolic effects of clenbuterol on skeletal muscle are mediated by beta-2-adrenoreceptor activation
25. The pharmacokinetics and residues of clenbuterol in veal calves
26. Clenbuterol residues in non-liver containing meat as a cause of collective food poisoning
27. Clinical and pharmacological profile in a clenbuterol epidemic poisoning of contaminated beef meat in Italy
28. Collective human food poisonings by clenbuterol residues in veal liver
29. A cluster of clenbuterol poisoning associated with the pork and pig offal in Hong Kong
30. Food poisoning related to consumption of illicit β-agonist in liver
31. Residues of the beta-agonist clenbuterol in tissues of medicated farm animals
32. Distribution, elimination, and residues of [14C]clenbuterol HCl in holstein calves
33. Cardiac, pulmonary and neuromuscular effects of clenbuterol and terbutaline compared with placebo
34. Spiropent (clenbuterol): Another choice for patients with chronic reversible airways obstruction